Oral Bioavailability of Two Solid Formulations of GLPG0634

NCT01915667 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 200 mg GLPG0634 as capsules, fasted
DRUG: 200 mg GLPG0634 as tablets, fasted
DRUG: 200 mg GLPG0634 as tablets, fed

Sponsor

Lakefront Biotherapeutics NV